Tuula Pirttilä

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

Tero Tapiola, Irina Alafuzoff, Sanna‐Kaisa Herukka et al. · Archives of Neurology · 2009 · 897 citations · Full text

Medicine, Neurology, Neuroscience +17

Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

Pieter Jelle Visser, Frans R.J. Verhey, Dirk L. Knol et al. · The Lancet Neurology · 2009 · 621 citations

Medicine, Neurology, Neuroscience +16

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease

Katharina Büerger, Michael Ewers, Tuula Pirttilä et al. · Brain · 2006 · 588 citations

Life Sciences, Neurology, Neuroscience +17

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease

Pankaj Mehta, Tuula Pirttilä, Sangita P. Mehta et al. · Archives of Neurology · 2000 · 586 citations

Life Sciences, Neurology, Neuroscience +16

EFNS guidelines for the diagnosis and management of Alzheimer’s disease

Jakub Hort, John T. O’Brien, Guido Gainotti et al. · European Journal of Neurology · 2010 · 489 citations · Full text

Medicine, Geriatric Medicine, Neurology +17